Research in cell death mechanism has kindled interest in PARP's (Poly (ADP-Ribose) Polymerase) intriguing role in necrosis and apoptosis. This book covers the clinical aspects of PARP inhibitors, an up-and-coming class of therapeutic agents that counteracts the damage done by free radicals.